The field of exosome therapeutics is rapidly evolving, with growing interest across oncology, regenerative medicine, and rare diseases. Recent exosome therapy news and exosome clinical trial news highlight how these nano-sized extracellular vesicles are unlocking new possibilities in targeted drug delivery and precision medicine. While questions like “Is exosome therapy FDA approved?” remain common, the reality is that exosome-based therapeutic development is still largely in the clinical stage. However, the expanding exosomes pipeline and increasing number of exosome therapy clinical trials suggest that regulatory milestones may not be far away.
In recent years, e...
